After news reports earlier this month that Chinese AI company Yi+ was raising a series B round, the company has recently announced its $15 million fundraising led by Haitong Securities. Meanwhile, XW Labs, a biopharmaceutical company focused on neurological disorders, has also bagged a $17.5 series B round from new and existing shareholders.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
